Comparison of the effectiveness of dialectical behavior therapy, fluvoxamine and their combination on depression in women with breast cancer
Advances in Pharmacology and Therapeutics Journal · 2022
DOI: 10.18502/aptj.v1i2.8670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Pharmacology and Therapeutics Journal, 2022. Verfasst von Mohsen Rafiei und 3 weiteren Autor:innen.
Themen: Depression
Abstract (Originalsprache)
Aims
This study aimed to compare the effectiveness of dialectical behavior therapy, Fluvoxamine, and their combination on depression in women with breast cancer.
Methods
This was a quasi-experimental study with a pre-and post-test design. The study population was women with breast cancer who were referred to health centers in region two in 2021. Forty-five people were selected by convenience method and then randomly placed in three groups (each n=15), including dialectical behavior therapy, Fluvoxamine (medication), and a combination of both. The first group received eight sessions of 90 minutes of dialectical behavior therapy, the second group received 200 mg of oral Fluvoxamine daily, and the third group received a combination of both methods. Data were collected by Depression Inventory and analyzed by multivariate analysis of covariance and Bonferroni post hoc test.
Results
The results showed that in the pre-test stage, the groups were not significantly different in terms of depression and dialectical behavior therapy (p> 0.05), but in the post-test stage, there was a significant difference (p
Zitieren
APA
Rafiei, M., Borujeni, A. A., Hosseini, A. S., & Dadashpour, Y. (2022). Comparison of the effectiveness of dialectical behavior therapy, fluvoxamine and their combination on depression in women with breast cancer. Advances in Pharmacology and Therapeutics Journal. https://doi.org/10.18502/aptj.v1i2.8670
Vancouver
Rafiei M, Borujeni AA, Hosseini AS, Dadashpour Y. Comparison of the effectiveness of dialectical behavior therapy, fluvoxamine and their combination on depression in women with breast cancer. Advances in Pharmacology and Therapeutics Journal. 2022. doi:10.18502/aptj.v1i2.8670
BibTeX
@article{Rafiei2022,
author = {Rafiei, Mohsen and Borujeni, Abolfazl Azizi and Hosseini, Azadeh Seif and Dadashpour, Yasmin},
title = {Comparison of the effectiveness of dialectical behavior therapy, fluvoxamine and their combination on depression in women with breast cancer},
journal = {Advances in Pharmacology and Therapeutics Journal},
year = {2022},
doi = {10.18502/aptj.v1i2.8670}
}
EUVIMED